Extension of clinical data structured into the ImmPort model and cross-study data exploration and visualization user interface
Extension of clinical data structured into the ImmPort model and cross-study data exploration and visualization user interface
批准号:
9797472
负责人:
Kari C. Nadeau
金额:
$23.48万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-06-01 至 2020-05-31
关键词:
AddressAgeAreaBiological AssayBiomedical ResearchCharacteristicsClinicalClinical DataClinical ResearchClinical TrialsCollaborationsCommon Data ElementDataData ElementData FilesDatabasesDevelopmentDiseaseDisease ProgressionDocumentationEnsureExerciseFemaleFlow CytometryFood HypersensitivityFutureGene ExpressionGoalsHemagglutinationHypersensitivityImageryImmune ToleranceImmunologicsImmunologyIndividualInformaticsMeasuresMethodsMiningModelingOrgan TransplantationParticipantPatientsPharmaceutical PreparationsProcessProtocols documentationPublishingRecurrenceReportingReproducibilityResearchResearch PersonnelResource SharingResourcesST14 geneScienceSpecific qualifier valueStandard ModelStandardizationStructureTerminologyTestingTextValidationVocabularyWorkbaseclinical developmentdata accessdata formatdata miningdata resourcedata sharingdatabase structuredesignexperiencehuman leukocyte antigen testinginterestmultimodalitynoveloncologyprototyperepositorysecondary analysistoolusabilityweb pageweb portal
中文摘要
项目摘要/摘要
共享生物医学研究数据有助于独立验证研究结果、设计未来临床
试验和重复使用数据来检验新的假说。共享数据的一个平台是免疫学数据库和
分析门户(ImmPort),这是一个公共仓库,提供对临床和机械数据的开放访问
目前有341项免疫学和临床研究。除了有价值的高吞吐量数据元素外,ImmPort
提供对来自临床研究的个人级别数据的访问。ImmPort上的许多临床研究都有
与它们相关联的大量数据,这些数据没有被注释和解析到结构化的ImmPort MySQL中
数据库模型,但以各种不同格式的单独文件提供。在这种形式中,数据不是
随时可用于数据挖掘或二次分析。我们将优先处理来自临床的非结构化数据
研究整合到结构化MySQL ImmPort模型中,以便于更好地访问和重复使用。我们进一步
将协调数据库中尚未建立首选术语但已使用的词汇
这对二次分析具有很高的兴趣。目前,ImmPort中跨研究的可用数据挖掘
对于没有信息学经验并因此依赖于关键字搜索的用户来说,这是一个挑战
ImmPort的网页。为了满足这一迫切需求,我们将开发一种交互式交叉研究数据探索
ImmPort模型中数据的可视化用户界面,包括创建交叉研究的功能
出口。新构建到ImmPort模型中的数据以及用户界面将集成到
ImmPort及其网页。几种疾病(如过敏、器官移植)的治疗依赖于
诱导免疫耐受。在Immport,几项研究集中在不同的疾病上,但有潜在的
关于免疫耐受的话题。我们将对共享的个人级别的临床和
这些研究的机制数据有助于确定临床发展的潜在普遍驱动因素
免疫耐受。这一分析将被用来开发交互式用户界面的逐步教程。
英文摘要
Project Summary/Abstract
Sharing of biomedical research data facilitates independent validation of findings, the design of future clinical
trials and the reuse of data to test new hypothesis. One platform to share data is the Immunology Database and
Analysis Portal (ImmPort), a public warehouse providing open access to clinical and mechanistic data from
currently 341 immunological and clinical studies. In addition to valuable high-throughput data elements, ImmPort
provides access to individual-level data from clinical studies. Many of these clinical studies in ImmPort have an
abundance of data associated with them that is not annotated and parsed into the structured ImmPort MySQL
database model but made available as separate files in various different formats. In this form the data are not
readily available for data mining or secondary analysis. We will prioritize the unstructured data from clinical
studies for integration into the structured MySQL ImmPort model to facilitate better access and reuse. We further
will harmonize the used vocabularies in the database for which a preferred terminology is not yet established but
which is of high interest for secondary analyses. Currently, the mining of available data across studies in ImmPort
is a challenge for users who have no experience in informatics and, therefore, rely on the keyword search on
ImmPort’s web page. To address this critical need, we will develop an interactive cross-study data exploration
and visualization user interface for data in the ImmPort model including the functionality to create cross-study
exports. The data newly structure into the ImmPort model as well as the user interface will be integrated into
ImmPort and its web page. The treatments of several diseases (e.g. allergies, organ transplantation) rely on the
induction of immune tolerance. In ImmPort serval studies focus on different diseases but with the underlying
topic of immune tolerance. We will perform a secondary analysis of the shared individual-level clinical and
mechanistic data of these studies towards the identification of potential universal drivers of developing clinical
immune tolerance. This analysis will be used to develop a step-by-step tutorial for the interactive user interface.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Clinical Core
-
批准号:10584556
-
项目类别:
-
资助金额:$27.6万
-
财政年份:2022
-
负责人:Kari C. Nadeau
-
依托单位:
Clinical Core
-
批准号:10419277
-
项目类别:
-
资助金额:$30.97万
-
财政年份:2022
-
负责人:Kari C. Nadeau
-
依托单位:
Air pollution disrupts Inflammasome Regulation in HEart And Lung Total Health (AIRHEALTH)
-
批准号:10460326
-
项目类别:
-
资助金额:$212.0万
-
财政年份:2021
-
负责人:Kari C. Nadeau
-
依托单位:
Administrative Core for the Air pollution disrupts Inflammasome Regulation in HEart And Lung Total Health (AIRHEALTH) Study
-
批准号:10269331
-
项目类别:
-
资助金额:$14.91万
-
财政年份:2021
-
负责人:Kari C. Nadeau
-
依托单位:
Clinical Core
-
批准号:10491675
-
项目类别:
-
资助金额:$53.79万
-
财政年份:2021
-
负责人:Kari C. Nadeau
-
依托单位:
Clinical Core
-
批准号:10687221
-
项目类别:
-
资助金额:$77.09万
-
财政年份:2021
-
负责人:Kari C. Nadeau
-
依托单位:
Administrative Core for the Air pollution disrupts Inflammasome Regulation in HEart And Lung Total Health (AIRHEALTH) Study
-
批准号:10684157
-
项目类别:
-
资助金额:$25.47万
-
财政年份:2021
-
负责人:Kari C. Nadeau
-
依托单位:
Air pollution disrupts Inflammasome Regulation in HEart And Lung Total Health (AIRHEALTH)
-
批准号:10684155
-
项目类别:
-
资助金额:$189.4万
-
财政年份:2021
-
负责人:Kari C. Nadeau
-
依托单位:
Interaction between genetic, lifestyle and environmental factors determining circulating angiotensin-converting enzyme 2 protein expression: implications for the severity of COVID-19 infection
-
批准号:10228516
-
项目类别:
-
资助金额:$22.94万
-
财政年份:2021
-
负责人:Kari C. Nadeau
-
依托单位:
Project 1 for the Air pollution disrupts Inflammasome Regulation in HEart And Lung Total Health (AIRHEALTH) Study
-
批准号:10684167
-
项目类别:
-
资助金额:$103.49万
-
财政年份:2021
-
负责人:Kari C. Nadeau
-
依托单位:
Project 1 for the Air pollution disrupts Inflammasome Regulation in HEart And Lung Total Health (AIRHEALTH) Study
-
批准号:10269334
-
项目类别:
-
资助金额:$55.16万
-
财政年份:2021
-
负责人:Kari C. Nadeau
-
依托单位:
Administrative Core for the Air pollution disrupts Inflammasome Regulation in HEart And Lung Total Health (AIRHEALTH) Study
-
批准号:10460327
-
项目类别:
-
资助金额:$14.91万
-
财政年份:2021
-
负责人:Kari C. Nadeau
-
依托单位:
Air pollution disrupts Inflammasome Regulation in HEart And Lung Total Health (AIRHEALTH)
-
批准号:10269330
-
项目类别:
-
资助金额:$213.9万
-
财政年份:2021
-
负责人:Kari C. Nadeau
-
依托单位:
ConProject-004
-
批准号:10905935
-
项目类别:
-
资助金额:$6.15万
-
财政年份:2021
-
负责人:Kari C. Nadeau
-
依托单位:
Interaction between genetic, lifestyle and environmental factors determining circulating angiotensin-converting enzyme 2 protein expression: implications for the severity of COVID-19 infection
-
批准号:10372177
-
项目类别:
-
资助金额:$17.52万
-
财政年份:2021
-
负责人:Kari C. Nadeau
-
依托单位:
Clinical Core
-
批准号:10190559
-
项目类别:
-
资助金额:$32.52万
-
财政年份:2021
-
负责人:Kari C. Nadeau
-
依托单位:
Project 1 for the Air pollution disrupts Inflammasome Regulation in HEart And Lung Total Health (AIRHEALTH) Study
-
批准号:10460330
-
项目类别:
-
资助金额:$53.28万
-
财政年份:2021
-
负责人:Kari C. Nadeau
-
依托单位:
Immune Tolerance Dysfunction in Pregnancy due to Ambient Air Pollution Exposure
-
批准号:10225619
-
项目类别:
-
资助金额:$37.68万
-
财政年份:2020
-
负责人:Kari C. Nadeau
-
依托单位:
Immune Tolerance Dysfunction in Pregnancy due to Ambient Air Pollution Exposure
-
批准号:10626886
-
项目类别:
-
资助金额:$42.88万
-
财政年份:2020
-
负责人:Kari C. Nadeau
-
依托单位:
Immune Tolerance Dysfunction in Pregnancy due to Ambient Air Pollution Exposure
-
批准号:10066711
-
项目类别:
-
资助金额:$39.05万
-
财政年份:2020
-
负责人:Kari C. Nadeau
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: